Hereditary hemochromatosis: A rare disease in Iran

Archives of Iranian Medicine

Volumn 9, Issue 1, 2006, Pages 78-80

  Nobakht, Hossein ^a   Merat, Shahin ^b   Malekzadeh, Reza ^b  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemochromatosis; Hereditary; Iran; Liver disease

Indexed keywords

FERRITIN; INSULIN; IRON;

ADULT; ARTICLE; ASCITES; CARDIOMYOPATHY; CASE REPORT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; ESOPHAGUS VARICES; FERRITIN BLOOD LEVEL; GASTROINTESTINAL ENDOSCOPY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEMOCHROMATOSIS; HEPATOSPLENOMEGALY; HUMAN; IRAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LEG EDEMA; LIVER FUNCTION TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; RARE DISEASE; TACHYCARDIA;

ADULT; HEMOCHROMATOSIS; HUMANS; IRAN; LIVER; MAGNETIC RESONANCE IMAGING; MALE; RARE DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31144444622     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Pietrangelo A. Hereditary hemochromatosis: a new took at an old disease. N Engl J Med. 2004; 350: 2383-2397.
2. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology. 1999; 116: 193-207.
3. Ansari R, Malekzadeh R, Ebrahimi-Daryani N, Mirdamadi MJ, Sohrabi MR, Mortazavi-Tabatabaei SA. A prospective study of the clinical and paraclinical features of Wilson's disease in Iran. Arch Irn Med. 2000; 3: 119-123.
4. Ziyad-Alizadeh B, Taheri H, Malekzadeh R, et al. Frequency of different causes of chronic hepatitis in patients referring to multiple centers in Tehran [in Persian]. Govaresh. 1998; 13/14: 13-23.
5. Azimi K, Sarrafi M, Alavian SM, et al. Frequency of different causes of cirrhosis in patients admitted in the Gastroenterology Ward of Shariati Hospital [in Persian]. Govaresh. 2002; 37/38: 19-26.
6. Bakayev V, Ignatiev I, Jazayeri M, Mohaghegh H, Zborovsky S, Zali MR. Duplex polymerase chain reaction-restriction fragment length polymorphism assay for rapid detection of HFE mutations-C282Y occurs with a low frequency in Tehran's population. J Hepatol. 2004; 40: 559-560.
7. Jensen PD. Evaluation of iron overload. Br J Haematol. 2004; 124: 697-711.
8. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000; 133: 329-337.
9. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997; 34: 275-278.
10. Lucotte G. Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis. 1998; 24: 433-438.
11. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999; 341: 718-724.